(Q48341481)

10 February 2018

title

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET. (English)

1 reference

10 February 2018

Christian la Fougère

9

0 references

Claus Belka

10

object named as

Claus Belka

1 reference

10 February 2018

author name string

Maximilian Niyazi

1

1 reference

10 February 2018

Nathalie Jansen

2

1 reference

10 February 2018

Ute Ganswindt

3

1 reference

10 February 2018

Silke Birgit Schwarz

4

1 reference

10 February 2018

Julia Geisler

5

1 reference

10 February 2018

Oliver Schnell

6

1 reference

10 February 2018

Karen Büsing

7

1 reference

10 February 2018

Sabina Eigenbrod

8

1 reference

10 February 2018

publication date

4 October 2012

1 reference

10 February 2018

Journal of Neuro-Oncology

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 February 2018

volume

110

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

389-395

1 reference

10 February 2018

Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Therapeutic options for recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Prediction of pathology and survival by FDG PET in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

FET-PET for malignant glioma treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Early metabolic responses in temozolomide treated low-grade glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Molecular imaging of gliomas with PET: opportunities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Irradiation and bevacizumab in high-grade glioma retreatment settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0980-7

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23054562

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-012-0980-7

1 reference

10 February 2018

1 reference

10 February 2018